Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar getmenews (< 20) Submitted: 9/20/2012 9:38:08 PM : Underperform Start Price: $23.86 ARIA Score: +10.66

Pump N Dump ?

Report this Post Reply

Featured Broker Partners


Advertisement